Acuta Capital Partners as of June 30, 2019
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 28 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | 21.2 | $60M | 2.4M | 24.52 | |
| Spdr Series Trust S&p Biotech Put Option (XBI) | 6.2 | $18M | 200k | 87.71 | |
| Kadmon Hldgs | 5.6 | $16M | 7.6M | 2.06 | |
| Biohaven Pharmaceutical Holding | 5.5 | $16M | 355k | 43.79 | |
| Adverum Biotechnologies | 5.0 | $14M | 1.2M | 11.89 | |
| Veracyte (VCYT) | 4.9 | $14M | 482k | 28.51 | |
| Arrowhead Pharmaceuticals (ARWR) | 4.5 | $13M | 479k | 26.50 | |
| Arvinas Ord (ARVN) | 4.3 | $12M | 551k | 21.99 | |
| Argenx Se Sponsored Adr (ARGX) | 4.1 | $12M | 81k | 141.58 | |
| Axsome Therapeutics (AXSM) | 4.0 | $11M | 438k | 25.75 | |
| Insmed Com Par $.01 (INSM) | 4.0 | $11M | 436k | 25.60 | |
| Milestone Pharmaceuticals (MIST) | 3.3 | $9.4M | 347k | 27.15 | |
| Athenex | 3.3 | $9.4M | 473k | 19.80 | |
| Protagonist Therapeutics (PTGX) | 2.9 | $8.1M | 672k | 12.11 | |
| Viewray (VRAYQ) | 2.6 | $7.4M | 843k | 8.81 | |
| Xenon Pharmaceuticals (XENE) | 2.5 | $6.9M | 702k | 9.86 | |
| Mirati Therapeutics | 2.3 | $6.4M | 63k | 103.01 | |
| Aurinia Pharmaceuticals (AUPH) | 2.2 | $6.2M | 935k | 6.58 | |
| Dicerna Pharmaceuticals | 2.2 | $6.1M | 385k | 15.75 | |
| IRIDEX Corporation (IRIX) | 1.9 | $5.3M | 1.2M | 4.55 | |
| Kalvista Pharmaceuticals (KALV) | 1.7 | $4.7M | 213k | 22.15 | |
| Amicus Therapeutics (FOLD) | 1.6 | $4.4M | 350k | 12.48 | |
| Crispr Therapeutics Namen Akt (CRSP) | 1.3 | $3.7M | 79k | 47.10 | |
| Immunomedics | 1.1 | $3.1M | 225k | 13.87 | |
| Assembly Biosciences | 0.8 | $2.1M | 158k | 13.49 | |
| Danaher Corporation (DHR) | 0.6 | $1.6M | 12k | 142.96 | |
| Chimerix (CMRX) | 0.4 | $1.2M | 280k | 4.32 | |
| Chembio Diagnostics Com New | 0.1 | $254k | 42k | 6.10 |
